Page last updated: 2024-08-17

carbostyril and Ventilator-Associated Pneumonia

carbostyril has been researched along with Ventilator-Associated Pneumonia in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fisher, K; Juang, P; Kollef, MH; Micek, ST; Trupka, T	1
Falagas, ME; Trigkidis, KK; Vardakas, KZ	1
Fujita, M; Ishikura, H; Kitamura, T; Matsumoto, T; Toyoshima, H; Watanabe, K; Yoshimura, C	1
Baek, MS; Camargo, A; Lynch, SV; Nguyen, A; Singh, G; Slusher, NA; Srinivasan, R; Wiener-Kronish, JP; Wu, B	1
De Waele, JJ; Deja, M; Diaz, E; Guven, M; Koulenti, D; Lisboa, T; Mañez, R; Martin-Loeches, I; Putensen, C; Rello, J; Ulldemolins, M	1

Reviews

1 review(s) available for carbostyril and Ventilator-Associated Pneumonia

Article	Year
Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review. International journal of antimicrobial agents, 2015, Volume: 45, Issue:3 Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Bronchiectasis; Cystic Fibrosis; Fosfomycin; Humans; Pneumonia, Ventilator-Associated; Quinolones; Respiratory Tract Infections; Treatment Outcome	2015

Article

Year

Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review.

International journal of antimicrobial agents, 2015, Volume: 45, Issue:3

Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Bronchiectasis; Cystic Fibrosis; Fosfomycin; Humans; Pneumonia, Ventilator-Associated; Quinolones; Respiratory Tract Infections; Treatment Outcome

2015

Other Studies

4 other study(ies) available for carbostyril and Ventilator-Associated Pneumonia

Article	Year
Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study. Critical care (London, England), 2017, 07-15, Volume: 21, Issue:1 Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Cross-Over Studies; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Monobactams; Pneumonia; Pneumonia, Ventilator-Associated; Prospective Studies; Quinolones; Respiration, Artificial; Statistics, Nonparametric	2017
[A case of hospital-acquired pneumonia caused by intermediately susceptible carbapenem Acinetobacter baumannii]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2010, Volume: 84, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Cross Infection; Humans; Male; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones	2010
Secretion of Pseudomonas aeruginosa type III cytotoxins is dependent on pseudomonas quinolone signal concentration. Microbial pathogenesis, 2010, Volume: 49, Issue:4 Topics: Gene Expression Regulation, Bacterial; Humans; Leukocidins; Oligopeptides; Pancreatic Elastase; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Quorum Sensing; Virulence Factors	2010
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. The European respiratory journal, 2011, Volume: 37, Issue:6 Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Europe; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Piperacillin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones; Respiration, Artificial; Severity of Illness Index; Treatment Outcome	2011